COVID-19 reinfections

被引:0
作者
Fabianova, K. [1 ]
Kyncl, J. [1 ,2 ]
Vlckova, I [3 ]
Jirincova, H. [4 ]
Kostalova, J. [1 ]
Liptakova, M. [1 ]
Orlikova, H. [1 ]
Sebestova, H. [3 ]
Limberkova, R. [4 ]
Mackova, B. [4 ]
Maly, M. [3 ]
机构
[1] Natl Inst Publ Hlth, Dept Infect Dis Epidemiol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Dept Epidemiol & Biostat, Prague, Czech Republic
[3] Natl Inst Publ Hlth, Dept Biostat, Prague, Czech Republic
[4] Natl Inst Publ Hlth, Dept Resp Intestinal & Exanthematous Viral Infect, Prague, Czech Republic
来源
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE | 2021年 / 70卷 / 01期
关键词
COVID-19; coronavirus; SARS-CoV-2; reinfection;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reports of SARS-CoV-2 reinfections are on the rise. This study focused on reinfections in patients with confirmed COVID-19 in the Czech Republic. Between 1 March 2020 and 9 November 2020, 362 084 cases with the onset of symptoms before 31 October 2020 were reported. Overall, 28 cases of symptomatic SARS-CoV-2 reinfections were identified, 11 in males and 17 in females, age range 25-80 years, median age 46 years. The interval between the first and second episodes of the disease ranged from 101 to 231 days, and the median interval was 201.5 days. During both symptomatic episodes, all patients have been tested by RT-PCR. Altogether 26 patients (92.9%) have been tested negative after recovery from the first episode of COVID-19. Symptomatic reinfections occurred in nearly 0.2% of all patients at risk. Most patients with reinfection had mild symptoms in both episodes, and only three episodes were moderate to severe. Thus, reinfections may have been underdiagnosed. In summary, COVID-19 reinfections are possible and not exceptional.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 50 条
  • [21] Diabetes and COVID-19
    Bouhanick, Beatrice
    Cracowski, Jean-Luc
    Faillie, Jean-Luc
    THERAPIE, 2020, 75 (04): : 327 - 333
  • [22] COVID-19 and water
    Bellie Sivakumar
    Stochastic Environmental Research and Risk Assessment, 2021, 35 : 531 - 534
  • [23] COVID-19 and Indonesia
    Setiati, Siti
    Azwar, Muhammad K.
    ACTA MEDICA INDONESIANA, 2020, 52 (01) : 84 - 89
  • [24] Pathogenesis of COVID-19
    Akpinar, Evrim Eylem
    EURASIAN JOURNAL OF PULMONOLOGY, 2020, 22 (04) : 8 - 11
  • [25] COVID-19 and HIV
    Paulina Posada-Vergara, Maria
    Carlos Alzate-Angel, Juan
    Martinez-Buitrago, Ernesto
    COLOMBIA MEDICA, 2020, 51 (02):
  • [26] Psychopharmacology of COVID-19
    Bilbul, Melanie
    Paparone, Patricia
    Kim, Anna M.
    Mutalik, Shruti
    Ernst, Carrie L.
    PSYCHOSOMATICS, 2020, 61 (05) : 411 - 427
  • [27] Epidemiology of COVID-19
    Dhar Chowdhury, Sudipta
    Oommen, Anu Mary
    JOURNAL OF DIGESTIVE ENDOSCOPY, 2020, 11 (01) : 3 - 7
  • [28] COVID-19 and the endothelium
    Jung, F.
    Krueger-Genge, A.
    Franke, R. P.
    Hufert, F.
    Kuepper, J. -H.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2020, 75 (01) : 7 - 11
  • [29] Genetics of COVID-19
    Raskin, Salmo
    JORNAL DE PEDIATRIA, 2021, 97 (04) : 378 - 386
  • [30] COVID-19 and hypopituitarism
    Frara, Stefano
    Loli, Paola
    Allora, Agnese
    Santini, Chiara
    di Filippo, Luigi
    Mortini, Pietro
    Fleseriu, Maria
    Giustina, Andrea
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (02) : 215 - 231